During the past decade, Center for Cancer Care at Exeter Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 18 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Center for Cancer Care at Exeter Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 10 trials, followed by "Radiation Therapy Oncology Group" with 5 trials sponsored, "NSABP Foundation Inc" with 4 trials sponsored, "SWOG Cancer Research Network" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Center for Cancer Care at Exeter Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 23 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Cancer and Leukemia Group B" with 3 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Center for Cancer Care at Exeter Hospital" are "Breast Cancer" (7 trials), "Prostate Cancer" (5 trials), "Colorectal Cancer" (3 trials), "Lung Cancer" (3 trials) and "Metastatic Cancer" (2 trials). Many other conditions were trialed in "Center for Cancer Care at Exeter Hospital" in a lesser frequency.

Most popular intervention types in "Center for Cancer Care at Exeter Hospital" are "Drug" (17 trials), "Other" (9 trials), "Radiation" (6 trials), "Biological" (2 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "placebo" (7 trials), "LHRH agonist" (2 trials), "Placebo" (2 trials), "cetuximab" (2 trials) and "cyclophosphamide" (2 trials). Other intervention names were less common.

The vast majority of trials in "Center for Cancer Care at Exeter Hospital" are 10 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Center for Cancer Care at Exeter Hospital". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Center for Cancer Care at Exeter Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Center for Cancer Care at Exeter Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".